Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PGE2 contributes to in vitro MSC-mediated inhibition of non-specific- and antigen-specific T cells proliferation in MS patients.
Evolution of tumefactive lesions in multiple sclerosis: A 12-year study with serial imaging in a single patient.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Acute Disseminated Encephalomyelitis Without Optic Neuritis Followed by Optic Neuritis in a Child Due to the Sudden Cessation of Steroid Therapy.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
Sex-biased chromatin and regulatory cross-talk between sex chromosomes, autosomes, and mitochondria.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Emerging stem cell therapies: treatment, safety, and biology.
Neuropharmacological Actions of Metformin in Stroke.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
Acute optic neuritis in multiple sclerosis.
New EMA Advice for PML Prevention With Fingolimod in MS
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.
Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.
Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
[Differential diagnosis of optic neuritis (review].
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Rapid dissemination of granular cell astrocytoma arising from periventricular stem cell regions in chronic multiple sclerosis.
Pages
« first
‹ previous
…
498
499
500
501
502
503
504
505
506
…
next ›
last »